Evidence map›Paper›PMID 22542184›Full record

ArticleNeuron2012

Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)δ-1 Subunit.

Assunta Senatore, Simona Colleoni, Claudia Verderio, Elena Restelli, Raffaella Morini, Steven B Condliffe, Ilaria Bertani, Susanna Mantovani, Mara Canovi, Edoardo Micotti and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Presynaptic αProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Review
  11. PrPFrontiers in molecular neuroscience · 2021
    Review
  12. Review
  13. Neuronal αPflugers Archiv : European journal of physiology · 2020
    Review
  14. Article
  15. Prion Protein in Glioblastoma Multiforme.International journal of molecular sciences · 2019
    Review
  16. Article
  17. CACHD1 is an α2δ-Like Protein That Modulates CaThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Assunta SenatoreDulbecco Telethon Institute, 20156 Milan, Italy.
Simona Colleoni
Claudia Verderio
Elena Restelli
Raffaella Morini
Steven B Condliffe
Ilaria Bertani
Susanna Mantovani
Mara Canovi
Edoardo Micotti
Gianluigi Forloni
Annette C Dolphin
Michela Matteoli
Marco Gobbi
Roberto Chiesa
Mario Negri Institute for Pharmacological Research · ITDulbecco Telethon Institute · ITNational Research Council · ITUniversity of Milan · ITUniversity College London · GB

Funding

Telethon TCR08005
6 · The paper itself

Abstract

How mutant prion protein (PrP) leads to neurological dysfunction in genetic prion diseases is unknown. Tg(PG14) mice synthesize a misfolded mutant PrP which is partially retained in the neuronal endoplasmic reticulum (ER). As these mice age, they develop ataxia and massive degeneration of cerebellar granule neurons (CGNs). Here, we report that motor behavioral deficits in Tg(PG14) mice emerge before neurodegeneration and are associated with defective glutamate exocytosis from granule neurons due to impaired calcium dynamics. We found that mutant PrP interacts with the voltage-gated calcium channel α(2)δ-1 subunit, which promotes the anterograde trafficking of the channel. Owing to ER retention of mutant PrP, α(2)δ-1 accumulates intracellularly, impairing delivery of the channel complex to the cell surface. Thus, mutant PrP disrupts cerebellar glutamatergic neurotransmission by reducing the number of functional channels in CGNs. These results link intracellular PrP retention to synaptic dysfunction, indicating new modalities of neurotoxicity and potential therapeutic strategies.

Indexed as

Age FactorsAnimalsAnimals, NewbornBiophysicsCalciumCalcium ChannelsCells, CulturedCerebellumDisease Models, AnimalElectric StimulationEndoplasmic ReticulumGlutamic AcidGreen Fluorescent ProteinsMagnetic Resonance ImagingMembrane PotentialsMiceCACNA2D3 protein, mouseCalciumCalcium Channelsenhanced green fluorescent proteinGlutamic AcidGreen Fluorescent ProteinsPrion ProteinsPrionsPrnp protein, mouse

Identifiers

PMID22542184
PMCPMC3339322
OpenAlexW2163048796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.